Cheniere Energy, Inc.
For the period ended Sep 30, 2026. Filed Oct 29, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 29, 2026
LNG$284.95+2.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
(in millions)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities | ||
| Net income | $1,716 | $3,861 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation, amortization and accretion expense | 1,146 | 979 |
| Share-based compensation expense | 190 | 140 |
| Reduction of right-of-use assets | 419 | 465 |
| Total losses (gains) on derivative instruments, net | 3,015 | (1,629) |
| Net cash provided by (used for) settlement of derivative instruments | (659) | 286 |
| Deferred taxes | (4) | 1,227 |
| Other, net | 61 | 40 |
| Changes in operating assets and liabilities: | ||
| Trade and other receivables | (50) | (587) |
| Inventory | (219) | 42 |
| Accounts payable and accrued liabilities | 279 | (672) |
| Total operating lease liabilities | (428) | (459) |
| Other non-current liabilities | (216) | — |
| Other, net | (126) | (209) |
| Net cash provided by operating activities | 5,124 | 3,484 |
| Cash flows from investing activities | ||
| Property, plant and equipment, net of proceeds from commissioning sales of LNG of $115 million and $94 million, respectively | (2,648) | (2,334) |
| Other, net | (37) | 71 |
| Net cash used in investing activities | (2,685) | (2,263) |
| Cash flows from financing activities | ||
| Proceeds from issuances of debt and borrowings | 4,446 | 1,262 |
| Redemptions and repayments of debt and borrowings | (3,317) | (1,617) |
| Distributions to NCI | (594) | (600) |
| Contributions from redeemable NCI | — | 108 |
| Redemption of redeemable NCI | (136) | — |
| Payments related to tax withholdings for share-based compensation | (40) | (50) |
| Repurchase of common stock, inclusive of excise taxes paid | (1,819) | (1,687) |
| Dividends to stockholders | (347) | (332) |
| Other, net | (160) | (94) |
| Net cash used in financing activities | (1,967) | (3,010) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash and cash equivalents | — | (3) |
| Net increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents | 472 | (1,792) |
| Cash, cash equivalents and restricted cash and cash equivalents—beginning of period | 1,584 | 3,190 |
| Cash, cash equivalents and restricted cash and cash equivalents—end of period | $2,056 | $1,398 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.